Cited by 1,521Cancer-related Molecular PathwaysHeat shock proteins researchPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 65 of the 72 references it cites were found in a registry or an index.

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Open access

Pomerantz, Jason, Schreiber-Agus, Nicole, Liégeois, Nanette J, Silverman, Adam, Alland, Leila, Chin, Lynda, Potes, Jason, Chen, Ken, Orlow, Irene, Lee, Han-Woong, Cordon-Cardo, Carlos, DePinho, Ronald A·1998·Cell

DOI 10.1016/s0092-8674(00)81400-2

Open this paper in CoChat — free account Open PDF

Abstract

The INK4a gene encodes two distinct growth inhibitors--the cyclin-dependent kinase inhibitor p16Ink4a, which is a component of the Rb pathway, and the tumor suppressor p19Arf, which has been functionally linked to p53. Here we show that p19Arf potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19Arf and MDM2 physically interact and that p19Rrf blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19Arf functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)81400-2

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312

Show all 72 references

Research works printed but not linked: 6

Brenner, 1996, Preferential loss of expression of p16INK4a rather than p19ARF in breast cancer, Clin. Cancer Res., 2, 1993
Elledge, 1996, A question of balance, Trends Biochem. Sci., 6, 388
Kinoshita, 1996, Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer, Cancer Res., 56, 5557
Quelle, 1995, Cloning and characterization of murine p16INK4a and p15INK4b genes, Oncogene, 11, 635
Schreiber-Agus, 1994, Evolutionary relationships and functional conservation among vertebrate Max-associated proteins, Oncogene, 9, 3167
Schreiber-Agus, 1997, An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3, Cell, 80, 777, 10.1016/0092-8674(95)90356-9 · DOI

Sorted by citations

Items 701–800 of 1,001

ARF Directly Binds DP1: Interaction with DP1 Coincides with the G1 Arrest Function of ARF
Datta, A., Sen, J., Hagen, J., Korgaonkar, C. K., Caffrey, M. S., Quelle, D. E., Hughes, D. E., Ackerson, T. J., Costa, R. H., & Raychaudhuri, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8024-8036.2005 · Cited by 46
Function and dysfunction of the human oncoprotein MDM2
Deb, S. P. (2002) · Frontiers in bioscience · doi:10.2741/a723 · Cited by 45
p14ARF Induces G2 Cell Cycle Arrest in p53- and p21-deficient Cells by Down-regulating p34cdc2 Kinase Activity
Normand, G., Hemmati, P., Verdoodt, B., von Haefen, C., Wendt, J., Güner, D., May, E., Dörken, B., & Daniel, P. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412330200 · Cited by 45
Retracted
Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features
Horie, S., Endo, K., Kawasaki, H., & Terada, T. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000201 · Cited by 44
A common variant in the CDKN2B gene on chromosome 9p21 protects against coronary artery disease in Americans of African ancestry
Kral, B. G., Mathias, R. A., Suktitipat, B., Ruczinski, I., Vaidya, D. M., Yanek, L. R., Quyyumi, A. A., Patel, R. S., Zafari, A. M., Vaccarino, V., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2010.171 · Cited by 44
Molecular biology of gliomas
Lassman, A. B. (2004) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-004-0043-3 · Cited by 44
p53 promotes adenoviral replication and increases late viral gene expression
Royds, J. A., Hibma, M. H., Dix, B. R., Hananeia, L., Russell, I. A., Wiles, A. K., Wynford‐Thomas, D., & Braithwaite, A. W. (2005) · Oncogene · doi:10.1038/sj.onc.1209185 · Cited by 44
Induction of apoptosis in cancer: new therapeutic opportunities
Ding, H., & Fisher, D. E. (2002) · Annals of Medicine · doi:10.1080/078538902321012405 · Cited by 44
The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
Modestou, M., Puig-Antich, V., Korgaonkar, C. K., Eapen, A. K., & Quelle, D. E. (2001) · PubMed · Cited by 44
Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes
Ayrault, O., Andrique, L., Larsen, C., & Seité, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207968 · Cited by 44
Functional and Physical Interaction of the Human ARF Tumor Suppressor with Tat-binding Protein-1
Pollice, A., Nasti, V., Ronca, R., Vivo, M., Iacono, M. L., Calogero, R., Calabrò, V., & Mantia, G. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310957200 · Cited by 46
Multiple Murine Double Minute Gene 2 (MDM2) Proteins Are Induced by Ultraviolet Light
Saucedo, L. J., Myers, C. D., & Perry, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8161 · Cited by 49
The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy
Damasio, M. P. S., Nascimento, C. S., de Andrade, L. M., de Oliveira, V. L., & Calzavara-Silva, C. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1021609 · Cited by 46
Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes
Taneja, P., Zhu, S., Maglic, D., Fry, E. A., Kendig, R. D., & Inoue, K. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7516 · Cited by 44
Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
Fairlie, W. D., & Lee, E. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062841 · Cited by 45
Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Węsierska‐Gądek, J., & Schmid, G. (2001) · PubMed · Cited by 43
Targeting the p53 Pathway in Ewing Sarcoma
Neilsen, P. M., Pishas, K. I., Callen, D. F., & Thomas, D. M. (2010) · Sarcoma · doi:10.1155/2011/746939 · Cited by 43
Metastasis-induction and apoptosis-protection by TWIST in gastric cancer cells
Feng, M.-Y., Wang, K., Song, H., Yu, H., Yu, Q., Shi, Q., & Geng, J. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9291-6 · Cited by 43
Identification of Novel ARF Binding Proteins by Two-Hybrid Screening
Tompkins, V. S., Hagen, J., Zediak, V. P., & Quelle, D. E. (2006) · Cell Cycle · doi:10.4161/cc.5.6.2560 · Cited by 43
ARF mutation accelerates pituitary tumor development in Rb +/− mice
Tsai, K. Y., MacPherson, D. P., Rubinson, D. A., Nikitin, A. Y., Bronson, R. T., Mercer, K. L., Crowley, D. G., & Jacks, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262499599 · Cited by 43
Regulated nuclear localization of stress-responsive factors: how the nuclear trafficking of protein kinases and transcription factors contributes to cell survival
Ferrigno, P. K., & Silver, P. A. (1999) · Oncogene · doi:10.1038/sj.onc.1203132 · Cited by 43
E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses
Liu, Y., & Zacksenhaus, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203996 · Cited by 43
Demystified ... cell cycle.
Gillett, C., & Barnes, D. M. (1998) · Molecular Pathology · doi:10.1136/mp.51.6.310 · Cited by 43
Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets
Chen, J., Riazifar, H., Guan, M., & Huang, T. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0264-1 · Cited by 42
Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding
Fan, S., Yuan, R., Ma, Y. X., Xiong, J., Meng, Q., Erdos, M. R., Zhao, J.-N., Goldberg, I. D., Pestell, R. G., & Rosen, E. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204666 · Cited by 42
Animal models of melanoma: Recent advances and future prospects
Bardeesy, N. M., Wong, K., DePinho, R. A., & Chin, L. (2000) · Advances in cancer research · doi:10.1016/s0065-230x(00)79004-x · Cited by 43
Self-citation
Role of Retinoblastoma Tumor Suppressor Protein in DNA Damage Response
Wang, S. N. J. Y. J. (2001) · Acta Oncologica · doi:10.1080/02841860152619098 · Cited by 42
Senescent cells at the crossroads of aging, disease, and tissue homeostasis
Kuehnemann, C., & Wiley, C. D. (2023) · Aging Cell · doi:10.1111/acel.13988 · Cited by 44
p53 regulation upon genotoxic stress: intricacies and complexities
Kumari, R., Kohli, S., & Das, S. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969653 · Cited by 41
Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
Mo, Q., Li, R., Adeegbe, D. O., Peng, G., & Chan, K. S. (2020) · Communications Biology · doi:10.1038/s42003-020-01491-2 · Cited by 41
A Non-Tumor Suppressor Role for Basal p19ARF in Maintaining Nucleolar Structure and Function
Apicelli, A. J., Maggi, L. B., Hirbe, A. C., Miceli, A. P., Olanich, M. E., Winkeler, C. L., Saporita, A. J., Kuchenreuther, M., Sanchez, J., Weilbaecher, K. N., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-07 · Cited by 41
MDM2 expression during mouse embryogenesis and the requirement of p53
Léveillard, T., Gorry, P., Niederreither, K., & Wasylyk, B. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00074-4 · Cited by 41
The human 1‐8D gene (IFITM2) is a novel p53 independent pro‐apoptotic gene
Daniel‐Carmi, V., Makovitzki‐Avraham, E., Reuven, E. M., Goldstein, I., Zilkha, N., Rotter, V., Tzehoval, E., & Eisenbach, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24669 · Cited by 41
Molecular pathobiology of pancreatic adenocarcinoma
King, T. C. (1998) · Frontiers in bioscience · doi:10.2741/a351 · Cited by 41
p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts
Khan, S. H., Guevara, C. I., Fujii, G., & Parry, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207824 · Cited by 41
Update on genetic events in the pathogenesis of melanoma
Halachmi, S., & Gilchrest, B. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200103000-00008 · Cited by 41
Development of a Model for Evaluating the Interaction Between Human Pre-B Acute Lymphoblastic Leukemic Cells and the Bone Marrow Stromal Cell Microenvironment
Shah, N., Oseth, L., & LeBien, T. W. (1998) · Blood · doi:10.1182/blood.v92.10.3817 · Cited by 41
Loss of the p21(Cip1/Waf1) cyclin kinase inhibitor results in propagation of horizontally transferred DNA.
Bergsmedh, A., Szeles, A., Spetz, A., & Holmgren, L. (2002) · PubMed · Cited by 41
Analysis of JNK, Mdm2 and p14ARF contribution to the regulation of mutant p53 stability
Buschmann, T., Minamoto, T., Wagle, N., Fuchs, S. Y., Adler, V., Mai, M., & Ronai, Z. A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3387 · Cited by 41
Loss of p21 disrupts p14ARF-induced G1 cell cycle arrest but augments p14ARF-induced apoptosis in human carcinoma cells
Hemmati, P., Normand, G., Verdoodt, B., von Haefen, C., Hasenjäger, A., Güner, D., Wendt, J., Dörken, B., & Daniel, P. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208579 · Cited by 40
Specific Contribution of p19ARF to Nitric Oxide-Dependent Apoptosis
Zeini, M., Través, P. G., López-Fontal, R., Pantoja, C., Matheu, A., Serrano, M., Boscá, L., & Hortelano, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3327 · Cited by 40
A Novel Nuclear Interactor of ARF and MDM2 (NIAM) That Maintains Chromosomal Stability
Tompkins, V. S., Hagen, J., Frazier, A. A., Lushnikova, T., Fitzgerald, M. P., Tommaso, A. D., Ladevèze, V., Domann, F. E., Eischen, C. M., & Quelle, D. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609612200 · Cited by 40
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene
Ameyar‐Zazoua, M., Wisniewska, M. B., Bakiri, L., Wagner, E. F., Yaniv, M., & Weitzman, J. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208424 · Cited by 42
Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression
Kabir, F. M. L., Alvarez, C. E., & Bird, R. (2015) · Veterinary Sciences · doi:10.3390/vetsci3010001 · Cited by 44
High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam, A. S. M., Foley, J. F., Devereux, T. R., Maronpot, R. R., & Massey, T. E. (1999) · PubMed · Cited by 40
Efficient replication of adenovirus despite the overexpression of active and nondegradable p53.
Koch, P., Gatfield, J., Löber, C., Hobom, U., Lenz-Stöppler, C., Roth, J., & Dobbelstein, M. (2001) · PubMed · Cited by 40
MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase varepsilon
Vlatković, N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3581 · Cited by 40
Proliferation, but Not Apoptosis, Is Associated with Distinct β-Catenin Expression Patterns in Non-Small-Cell Lung Carcinomas
Kotsinas, A., Evangelou, K., Zacharatos, P., Kittas, C. N., & Gorgoulis, V. G. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64440-9 · Cited by 40
Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes
Pfister, C., LaRue, H., Moore, L., Lacombe, L., Veilleux, C., Têtu, B., Meyer, F., & Fradet, Y. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000120)89:1 · Cited by 30
p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells
Unnikrishnan, I., Radfar, A., Jenab-Wolcott, J., & Rosenberg, N. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4825 · Cited by 40
Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway
Lv, H., Liu, R., Fu, J., Yang, Q., Shi, J., Chen, P., Ji, M., Shi, B., & Hou, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.947203 · Cited by 39
p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
Zeng, Y., Kotake, Y., Pei, X., Smith, M. D., & Xiong, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3483 · Cited by 41
Tp53 and its potential therapeutic role as a target in bladder cancer
Ciccarese, C., Massari, F., Blanca, A., Tortora, G., Montironi, R., Liang Cheng, C., Scarpelli, M., Raspollini, M. R., Vau, N., Fonseca, J., et al. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1297798 · Cited by 39
Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors
Kobayashi, A. (2020) · Cancers · doi:10.3390/cancers12092681 · Cited by 41
CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14ARF degradation
Zhang, P., Gao, K., Zhang, L., Sun, H., Zhao, X., Liu, Y., Lv, Z., Shi, Q., Chen, Y., Jiao, D., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00890-0 · Cited by 39
Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications
Baithun, S. I., Naase, M., Blanes, A., & Díaz‐Cano, S. J. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000289 · Cited by 39
Simulation-Based Validation of the p53 Transcriptional Activity with Hybrid Functional Petri Net
Doi, A., Nagasaki, M., Matsuno, H., & Miyano, S. (2006) · In Silico Biology · doi:10.3233/isb-00216 · Cited by 39
MDM2/p53 protein expression in the development of colorectal adenocarcinoma
Abdel‐Fattah, G., Yoffe, B., Krishnan, B., Khaoustov, V. I., & Itani, K. M. F. (2000) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(00)80041-4 · Cited by 39
Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2
Clark, P. A., Llanos, S., & Peters, G. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205558 · Cited by 39
Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner
Boutell, C., & Everett, R. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8068-8077.2004 · Cited by 42
Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-Myc
Benanti, J. A., Wang, M. L., Myers, H. E., Robinson, K. L., Grandori, C., & Galloway, D. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0372 · Cited by 39
Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents
Mayhew, C. N., Perkin, L. M., Zhang, X., Sage, J., Jacks, T., & Knudsen, E. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207503 · Cited by 39
Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
Stadler, W. M., Steinberg, G. D., Yang, X. J., Hagos, F., Turner, C., & Olopade, O. I. (2001) · PubMed · Cited by 39
Molecular genetic analysis of non‐astrocytic gliomas
Tong, Ng, H., Pang, Hui, Ko, & Lee (1999) · Histopathology · doi:10.1046/j.1365-2559.1999.00603.x · Cited by 39
Induction of Nevi and Skin Tumors in Ink4a/Arf Xpa Knockout Mice by Neonatal, Intermittent, or Chronic UVB Exposures
van Schanke, A., van Venrooij, G. M. C. A. L., Jongsma, M. J., Banus, H. A., Mullenders, L. H. F., van Kranen, H. J., & de Gruijl, F. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2476 · Cited by 38
The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality
Bray, C., Balcells, C. D., McNeish, I. A., & Keun, H. C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1264785 · Cited by 42
The T-box transcription factor TBX3 drives proliferation by direct repression of the p21WAF1 cyclin-dependent kinase inhibitor
Willmer, T., Hare, S., Peres, J., & Prince, S. (2016) · Cell Division · doi:10.1186/s13008-016-0019-0 · Cited by 40
HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma
Laporte, A. N., Barrott, J. J., Yao, R. J. R., Poulin, N., Brodin, B. A., Jones, K. B., Underhill, T. M., & Nielsen, T. O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169407 · Cited by 38
Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line
Lecane, P. S., Kiviharju, T. M., Sellers, R. G., & Peehl, D. M. (2003) · The Prostate · doi:10.1002/pros.10197 · Cited by 38
Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene
Gressani, K. M., Leone‐Kabler, S., O’Sullivan, M. G., Case, L. D., Malkinson, A. M., & Miller, M. S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2159 · Cited by 38
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System
Nieto‐Sampedro, M., Valle‐Argos, B., Gómez‐Nicola, D., Fernández‐Mayoralas, A., & Nieto‐Díaz, M. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7685 · Cited by 39
The Structure of the Vertebrate Lens
Kuszak, J. R., & Costello, M. J. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.005 · Cited by 38
ARF Tumor Suppressor Induces Mitochondria-dependent Apoptosis by Modulation of Mitochondrial Bcl-2 Family Proteins
Nakazawa, Y., Kamijo, T., Koike, K., & Noda, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300510200 · Cited by 38
Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
Itoshima, T., Fujiwara, T., Waku, T., Shao, J., Kataoka, M., Yarbrough, W. G., Liu, T.-J., Roth, J., Tanaka, N., & Kodama, M. (2000) · PubMed · Cited by 38
Altered Expression of the Cell Cycle Regulatory Molecules pRb, p53 and MDM2 Exert a Synergetic Effect on Tumor Growth and Chromosomal Instability in Non-small Cell Lung Carcinomas (NSCLCs)
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Mariatos, G., Liloglou, T., Vogiatzi, T., Foukas, P., Rassidakis, G. Z., Garinis, G. A., Ioannides, T., et al. (2000) · Molecular Medicine · doi:10.1007/bf03402115 · Cited by 38
Expression Patterns of Cell Cycle Components in Sporadic and Neurofibromatosis Type 1-Related Malignant Peripheral Nerve Sheath Tumors
Ågesen, T. H., Flørenes, V. A., Molenaar, W. M., Lind, G. E., Berner, J., Plaat, B. E. C., Komdeur, R., Myklebost, O., van den Berg, E., & Lothe, R. A. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.1.74 · Cited by 38
Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates
Simpson, L., & Galanis, E. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.11.1593 · Cited by 38
Inhibiting CDK inhibitors: new lessons from DNA tumor viruses
Funk, J. O. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01242-0 · Cited by 38
Melanoma Genetics: An Update on Risk-Associated Genes
Udayakumar, D., & Tsao, H. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.03.011 · Cited by 39
Molecular Biology of Pancreatic Ductal Adenocarcinoma Progression
Rhim, A. D., & Stanger, B. Z. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00002-7 · Cited by 39
Gradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A
Kumazawa, T., Nishimura, K., Katagiri, N., Hashimoto, S., Hayashi, Y., & Kimura, K. (2015) · Scientific Reports · doi:10.1038/srep10854 · Cited by 38
The Nucleolar Protein Myb-binding Protein 1A (MYBBP1A) Enhances p53 Tetramerization and Acetylation in Response to Nucleolar Disruption
Ono, W., Hayashi, Y., Yokoyama, W., Kuroda, T., Kishimoto, H., Ito, I., Kimura, K., Akaogi, K., Waku, T., & Yanagisawa, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474049 · Cited by 39
Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways
Walter, G., & Ruediger, R. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19057 · Cited by 38
TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation
Chio, I. I. C., Sasaki, M., Ghazarian, D., Moreno, J. C. A., Done, S. J., Ueda, T., Inoue, S., Chang, Y., Chen, N., & Mak, T. W. (2012) · Nature Cell Biology · doi:10.1038/ncb2496 · Cited by 41
Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo
Wahl, G. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401911 · Cited by 37
Role for PP2A in ARF signaling to p53
Moule, M. G., Collins, C. H., McCormick, F. P., & Fried, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405533101 · Cited by 37
Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
Nambiar, P. R., Giardina, C. A., Guda, K., Aizu, W., Raja, R. G., & Rosenberg, D. W. (2002) · PubMed · Cited by 37
Inhibition of v-Abl transformation by p53 and p19ARF
Cong, F., Zou, X., Hinrichs, K., Calame, K. L., & Goff, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203290 · Cited by 38
E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation
Nip, J., Strom, D. K., Eischen, C. M., Cleveland, J. L., Zambetti, G. P., & Hiebert, S. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204171 · Cited by 37
p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts
Kurokawa, K., Tanaka, T., & Kato, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202628 · Cited by 37
Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma
Soufir, N., Lacapère, J.-J., Bertrand, G., Matichard, E., Meziani, R., Mirebeau‐Prunier, D., Descamps, V., Gérard, B., Archimbaud, A., Ollivaud, L., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601503 · Cited by 37
Anticancer Drug Toxicity: Prevention, Management, and Clinical Pharmacokinetics
Damjanov, N. (2000) · Modern Pathology · doi:10.1038/modpathol.3880173 · Cited by 37
Apoptosis induced by 1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic analysis
Fu, W.-M., Zhang, J.-F., Wang, H., Tan, H., Wang, W.-M., Chen, S., Zhu, X. M., Chan, T.-M., Tse, C.-M., Leung, K., et al. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0729-y · Cited by 36
Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo
Merkel, C. A., Medrano, R. F. V., Baraúna, V. G., & Strauss, B. E. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.23 · Cited by 36
Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner #
Zhu, Z., Luo, Z., Li, Y., Ni, C.-R., Li, H., & Zhu, M.-H. (2008) · Hepatology · doi:10.1002/hep.22675 · Cited by 36
Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53
Valente, L. J., Grabow, S., Vandenberg, C. J., Strasser, A., & Janic, A. (2015) · Oncogene · doi:10.1038/onc.2015.457 · Cited by 37
Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells.
Qu, K., Lin, T. Y., Wei, J., Meng, F., Wang, Z., Huang, Z., Wan, Y., Song, S., Liu, S., Chang, H., et al. (2013) · PubMed · Cited by 36
Negative auto-regulators trap p53 in their web
Zhou, X. Y., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 37
Expression of p14, MDM2, and MDM4 in human retinoblastoma
Guo, Y., Pajovic, S., & Gallie, B. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.055 · Cited by 36
The Inhibitor of Cyclin-Dependent Kinase 4a/Alternative Reading Frame ( INK4a/ARF ) Locus Encoded Proteins p16INK4a and p19ARF Repress Cyclin D1 Transcription through Distinct cis Elements
D’Amico, M., Wu, K., Fu, M., Rao, M., Albanese, C., Russell, R. G., Lian, H., Bregman, D. B., White, M. A., & Pestell, R. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2519 · Cited by 38

Authors: Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., Cordon-Cardo, C., & DePinho, R. A.
Affiliations: Albert Einstein College of Medicine (US)
Memorial Sloan Kettering Cancer Center (US)
Corresponding author: DePinho, Ronald A
ORCID: Pomerantz, Jason
Liégeois, Nanette J
Chen, Ken
Orlow, Irene
Lee, Han-Woong
DePinho, Ronald A
Venue: Cell
Publisher: Elsevier BV
Published: 1998-03
Volume: 92
Issue: 6
Pages: 713-723
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)81400-2
OpenAlex: W2039463309
Cited by: 1,521
References: 72
Citations by year: 2026: 4 · 2025: 10 · 2024: 6 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 19 · 2019: 16 · 2018: 12 · 2017: 24 · 2016: 27 · 2015: 32 · 2014: 44 · 2013: 44 · 2012: 47
FWCI: 64.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5617 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 47179, CA 47538, CADK97650, P01CA047179)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: p19ARF, INK4A, MDM2, p53, tumor suppression, protein-protein interaction, p53 degradation, p53 transactivation, oncogenic transformation, Rb pathway, viral oncoproteins, dominant-negative mutant
MeSH terms: Animals, Biotin, Cell Line, Deoxyuracil Nucleotides, Lens, Crystalline, Neoplasm Proteins, Nuclear Proteins, Osteoblasts, Proteins, Proto-Oncogene Proteins, Staining and Labeling, Transformation, Genetic, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Genes, p16, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2, DNA Fragmentation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks